Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study.
Lammers SWM, Meegdes M, Vriens IJH, Voogd AC, de Munck L, van Nijnatten TJA, Keymeulen KBMI, Tjan-Heijnen VCG, Geurts SME. Lammers SWM, et al. Among authors: van nijnatten tja. ESMO Open. 2024 Apr 26;9(5):103008. doi: 10.1016/j.esmoop.2024.103008. Online ahead of print. ESMO Open. 2024. PMID: 38677006 Free PMC article.
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
Geurts SME, Ibragimova KIE, Ding N, Meegdes M, Erdkamp F, Heijns JB, Tol J, Vriens BEPJ, Dercksen MW, Aaldering KNA, Pepels MJAE, van de Winkel L, Peters NAJB, van de Wouw AJ, Maaskant SAJG, Teeuwen-Dedroog NJA, van Nijnatten TJA, de Boer M, Tjan-Heijnen VCG. Geurts SME, et al. Among authors: van nijnatten tja. Breast Cancer Res Treat. 2024 Jun;205(2):287-302. doi: 10.1007/s10549-023-07235-0. Epub 2024 Feb 21. Breast Cancer Res Treat. 2024. PMID: 38381274 Free PMC article.
Contrast-enhanced breast imaging: Current status and future challenges.
van Nijnatten TJA, Morscheid S, Baltzer PAT, Clauser P, Alcantara R, Kuhl CK, Wildberger JE. van Nijnatten TJA, et al. Eur J Radiol. 2024 Feb;171:111312. doi: 10.1016/j.ejrad.2024.111312. Epub 2024 Jan 12. Eur J Radiol. 2024. PMID: 38237520 Free article. Review.
Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI).
Schiaffino S, Cozzi A, Clauser P, Giannotti E, Marino MA, van Nijnatten TJA, Baltzer PAT, Lobbes MBI, Mann RM, Pinker K, Fuchsjäger MH, Pijnappel RM; European Society of Breast Imaging (EUSOBI). Schiaffino S, et al. Among authors: van nijnatten tja. Eur Radiol. 2024 Jan 16. doi: 10.1007/s00330-023-10574-7. Online ahead of print. Eur Radiol. 2024. PMID: 38227202
Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis.
Ploumen RAW, Claassens EL, Kooreman LFS, Keymeulen KBMI, van Kats MACE, Gommers S, Siesling S, van Nijnatten TJA, Smidt ML. Ploumen RAW, et al. Among authors: van nijnatten tja. Breast Cancer Res Treat. 2023 Sep;201(2):227-235. doi: 10.1007/s10549-023-07012-z. Epub 2023 Jul 3. Breast Cancer Res Treat. 2023. PMID: 37395816 Free PMC article.
57 results